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AQUATIC ANIMAL DRUG APPROVAL PARTNERSHIP PROGRAM FUNDING 
 
WHEREAS, the Aquatic Animal Drug Approval Partnership Program (AADAP) of the U.S. Fish and 
Wildlife Service (USFWS) serves an essential and unique federal role in drug approvals for public and 
tribal activities in aquaculture and fisheries management; and 
 
WHEREAS, AADAP currently provides 21 Investigational New Animal Drugs (INAD) that would not be 
otherwise available to control stress in our nation’s fish hatcheries and in the wild, initiate spawning for 
key species, and reduce preventable disease outbreaks; and 
 
WHEREAS, AADAP provides services to 48 states including 237 public programs and 38 state fish and 
wildlife agencies; and 
 
WHEREAS, the National INAD program administered by AADAP is essential to the restoration, recovery, 
and management activities of state, federal and tribal fish and wildlife agencies for 40 threatened and 
endangered (T&E) species and numerous other native species of concern; and 
 
WHEREAS, AADAP is an irreplaceable partner in a collaborative aquatic drug approval effort that 
includes state fish and wildlife agencies, the USFWS, the U.S. Geological Survey (USGS), the National 
Oceanic and Atmospheric Administration–National Marine Fisheries Service (NOAA-NMFS), the Food 
and Drug Administration (FDA), private aquaculture and numerous drug companies; and 
 
WHEREAS, the USFWS is an active member of the five-year Memorandum of Agreement between 
USFWS, USGS, NOAA-NMFS, and the Association of Fish and Wildlife Agencies (AFWA) to continue 
joint aquatic drug approval activities through October 10, 2017; and, 
 
WHEREAS, the 2013 Strategic Vision for Fish and Aquatic Resource Conservation in the Fish and 
Wildlife Service recently released by the Sport Fishing and Boating Partnership Council specifically 
identifies AADAP’s “essential and unduplicated services to the USFWS and its partners” and outlines 
individual Activity and Outcome objectives for the program; and 
 
WHEREAS, the USFWS has reduced the FY2014 AADAP budget by $400,000 and is proposing zeroing 
out the budget in FY2015 in favor of a user pay model; and 
 
WHEREAS the states have already invested over seven million dollars in the development of the Federal-
State Aquaculture Drug Approval Partnership Project; and  
 
WHEREAS, the states are now dependent on the federal investment to continue operating this 
Partnership; and 
 
WHEREAS, the states, to assist the U.S. Fish and Wildlife Service (USFWS) manage its federal 
obligations under the Endangered Species Act, use drugs to treat federally-listed threatened and 
endangered species while they are propagated in state operated hatcheries and in field based fishery 
management; and 
 
WHEREAS, federally recognized Treaty Tribes use drugs to manage fish production for subsistence and 
traditional uses;  
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NOW THEREFORE, BE IT RESOLVED that the Association of Fish and Wildlife Agencies strongly 
encourages the U.S. Fish and Wildlife Service to work closely with the Fisheries and Water Resources 
Policy Committee and the Drug Approval Working Group to: 
 
1. Coordinate efforts to obtain full funding for the FY2014 AADAP budget through various strategies 
both within and outside of the USFWS budget to cover the estimated $300,000 deficit; 
 
2. Maintain full operations of AADAP and the National INAD program throughout the FY2014 budget 
year; and 
 
3. Revisit the importance of the AADAP program for FY2015 and beyond to develop annual budget 
strategies that include adequate base funding to maintain and insure continuation of collaborative 
drug approval efforts. 
 
 
Submitted by the Drug Approval Working Group of the Fisheries and Water Resources Policy Committee 
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